UBS analyst Patrick Rafaisz upgraded EMS-Chemie (EMSHF) to Buy from Neutral with a price target of CHF 720, up from CHF 670. With shares trading near six year lows and almost 50% off their 2021/22 peak with EPS in CHF flat over the same period, the firm says the “chemistry is finally right” and expresses confidence that “the worst is now behind.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMSHF: